A carregar...
A CD138-Independent Strategy to Detect Minimal Residual Disease and Circulating Tumour Cells in Multiple Myeloma
CD138 (also termed SDC1) has been the gold-standard surface marker to detect multiple myeloma (MM) cells for decades; however, drug-resistant residual and circulating MM cells were shown to have lower expression of this marker. In this study, we have shown that residual MM cells following bortezomib...
Na minha lista:
| Publicado no: | Br J Haematol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4918510/ https://ncbi.nlm.nih.gov/pubmed/26729247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.13927 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|